Lipton A - Search Results

1

Impact of skeletal complications on patients' quality of life, mobility, and functional independence.

Costa L, Badia X, Chow E, Lipton A, Wardley A. Costa L, et al. Among authors: lipton a. Support Care Cancer. 2008 Aug;16(8):879-89. doi: 10.1007/s00520-008-0418-0. Epub 2008 Apr 8. Support Care Cancer. 2008. PMID: 18392862 Review.

2

Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases.

Costa L, Lipton A, Coleman RE. Costa L, et al. Among authors: lipton a. Support Cancer Ther. 2006 Apr 1;3(3):143-53. doi: 10.3816/SCT.2006.n.012. Support Cancer Ther. 2006. PMID: 18632488

3

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer.

Brown JE, Cook RJ, Lipton A, Costa L, Coleman RE. Brown JE, et al. Among authors: lipton a. Breast Cancer Res Treat. 2010 Oct;123(3):767-79. doi: 10.1007/s10549-010-0981-1. Epub 2010 Jun 24. Breast Cancer Res Treat. 2010. PMID: 20574672

4

Anticancer evidence for zoledronic acid across the cancer continuum.

Costa L, Harper P, Coleman RE, Lipton A. Costa L, et al. Among authors: lipton a. Crit Rev Oncol Hematol. 2011 Feb;77 Suppl 1:S31-7. doi: 10.1016/S1040-8428(11)70006-3. Crit Rev Oncol Hematol. 2011. PMID: 21353179 Review.

5

Treatment of bone metastases before the onset of pain.

Costa L, Lipton A, Hadji P, Chen YM, Kosmidis P. Costa L, et al. Among authors: lipton a. Int J Clin Oncol. 2013 Jun;18(3):531-8. doi: 10.1007/s10147-012-0414-8. Epub 2012 May 11. Int J Clin Oncol. 2013. PMID: 22572805 Clinical Trial.

6

Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status.

Costa L, Demers LM, Gouveia-Oliveira A, Schaller J, Costa EB, de Moura MC, Lipton A. Costa L, et al. Among authors: lipton a. J Clin Oncol. 2002 Feb 1;20(3):850-6. doi: 10.1200/JCO.2002.20.3.850. J Clin Oncol. 2002. PMID: 11821470

7

Bone turnover markers: tools for prognosis and monitoring response to bisphosphonates?

Lipton A, Costa L, Coleman RE. Lipton A, et al. Breast Dis. 2011;33(2):59-69. doi: 10.3233/BD-2010-0327. Breast Dis. 2011. PMID: 22142664 Review.

8

N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal Metastases.

Ferreira AR, Alho I, Shan N, Matias M, Faria M, Casimiro S, Leitzel K, Ali S, Lipton A, Costa L. Ferreira AR, et al. Among authors: lipton a. Oncologist. 2016 Dec;21(12):1418-1426. doi: 10.1634/theoncologist.2015-0527. Epub 2016 Aug 17. Oncologist. 2016. PMID: 27534575 Free PMC article.

9

Biochemical markers and skeletal metastases.

Demers LM, Costa L, Lipton A. Demers LM, et al. Among authors: lipton a. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S138-47. doi: 10.1097/01.blo.0000092979.12414.54. Clin Orthop Relat Res. 2003. PMID: 14600604 Review.

10

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases.

Lobo-Martins S, Ferreira AR, Mansinho A, Casimiro S, Leitzel K, Ali S, Lipton A, Costa L. Lobo-Martins S, et al. Among authors: lipton a. Cancers (Basel). 2020 Jul 24;12(8):2034. doi: 10.3390/cancers12082034. Cancers (Basel). 2020. PMID: 32722128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page